California’s Plan for Cheaper Insulin Collides With Big Pharma’s Price Cuts

By BY BENJAMIN RYAN from NYT Health https://ift.tt/2Gdap8H
via IFTTT
Health
Diabetes, Drugs (Pharmaceuticals), Insulin, Prices (Fares, Fees and Rates), Discount Selling, Generic Brands and Products, Inflation Reduction Act of 2022, Law and Legislation, Government Contracts and Procurement
New York Times
March 24, 2023 at 08:30PM